The Germany generic injectable market is witnessing remarkable growth, with projections indicating an impressive compound annual growth rate (CAGR) of 7.2%. The market is expected to expand from USD 9.1 million in 2025 to a substantial USD 18.3 million by 2035. As the largest pharmaceutical market in Europe, Germany boasts a well-established healthcare infrastructure, ensuring …